Skip to main content

Table 6 Logistic regression analysis for mRS3-6 and neurological deterioration

From: Baseline platelet count may predict short-term functional outcome of cerebral infarction

mRS3-6

Neurological deterioration

PltQ

P-value

Odds

95%CI

PltQ

P-value

Odds

95%CI

Q1

0.079

2.159

0.914–5.101

Q1

0.020

6.634

1.352–32.557

Q2

0.837

1.107

0.422–2.900

Q2

0.078

4.433

0.848–23.164

Q3

 

ref

 

Q3

 

ref

 

Q4

0.013

1.674

1.253–6.681

Q4

0.007

8.765

1.827–42.035

  1. PltQ, platelet quartiles; mRS3-6, modified Rankin scale ≥ 3
  2. including factors with p < 0.2 by univariate analysis
  3. mRS3-6; sex, dyslipidemia, CE, ACE premedication, diuretics premedication, statin premedication, WBC, Af, NIHSS > 8
  4. deterioration; anticoagulant therapy, SVD, ATBI, BAD, WBC, Hb, NIHSS > 8